 Alzheimers Dementia: The Journal of the Alzheimers Association, the prestigious peer-reviewed scientific journal, today has published the results of Grifols AMBAR study. This clinical trial was designed to assess the effects of plasma protein replacement therapy in patients experiencing either mild or moderate stages of Alzheimers disease AD. 